These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9146775

  • 1. In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity.
    Arnestad JS, Kleveland PM, Waldum HL.
    Aliment Pharmacol Ther; 1997 Apr; 11(2):355-8. PubMed ID: 9146775
    [Abstract] [Full Text] [Related]

  • 2. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion.
    Blum RA, Shi H, Karol MD, Greski-Rose PA, Hunt RH.
    Clin Ther; 1997 Apr; 19(5):1013-23. PubMed ID: 9385488
    [Abstract] [Full Text] [Related]

  • 3. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M, Ashida K, Umegaki E, Miyoshi H, Katsu K.
    J Clin Gastroenterol; 1995 Apr; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [Abstract] [Full Text] [Related]

  • 4. The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine.
    van Herwaarden MA, Samsom M, van Nispen CH, Mulder PG, Smout AJ.
    Aliment Pharmacol Ther; 1999 Jun; 13(6):731-40. PubMed ID: 10383501
    [Abstract] [Full Text] [Related]

  • 5. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.
    Hatlebakk JG, Katz PO, Camacho-Lobato L, Castell DO.
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1267-72. PubMed ID: 11012470
    [Abstract] [Full Text] [Related]

  • 6. Determining the optimal dose of lansoprazole injection by 24-hour intragastric pH monitoring.
    Sugiyama M, Aoki T, Matsuo Y.
    J Clin Gastroenterol; 1995 Oct; 20 Suppl 2():S14-6. PubMed ID: 7594331
    [Abstract] [Full Text] [Related]

  • 7. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
    Katz PO, Hatlebakk JG, Castell DO.
    Aliment Pharmacol Ther; 2000 Jun; 14(6):709-14. PubMed ID: 10848653
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study.
    Propst A, Propst T, Judmaier G.
    Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354
    [Abstract] [Full Text] [Related]

  • 9. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M, Freeman J, Castell D.
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [Abstract] [Full Text] [Related]

  • 10. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
    Hedenström H, Alm C, Kraft M, Grahnén A.
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1137-41. PubMed ID: 9663842
    [Abstract] [Full Text] [Related]

  • 11. Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans.
    Bruley des Varannes S, Duquesnoy C, Mamet JP, Slama A, Galmiche JP, Scarpignato C.
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1155-61. PubMed ID: 9845405
    [Abstract] [Full Text] [Related]

  • 12. Effect of omeprazole, lansoprazole, and ranitidine on the DNA synthesis of mononuclear cells.
    Peddicord TE, Olsen KM, Collier DS.
    Crit Care Med; 1999 Jan; 27(1):90-4. PubMed ID: 9934899
    [Abstract] [Full Text] [Related]

  • 13. A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.
    Nishina K, Mikawa K, Maekawa N, Takao Y, Shiga M, Obara H.
    Anesth Analg; 1996 Apr; 82(4):832-6. PubMed ID: 8615506
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine.
    Ley LM, Becker A, Lühmann R, Sander P, Lücker PW.
    Methods Find Exp Clin Pharmacol; 2005 Apr; 27(1):25-9. PubMed ID: 15834456
    [Abstract] [Full Text] [Related]

  • 15. Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers.
    Müller P, Göksu MA, Fuchs W, Schlüter F, Simon B.
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1225-9. PubMed ID: 10971240
    [Abstract] [Full Text] [Related]

  • 16. Age-dependent eradication of Helicobacter pylori with dual therapy.
    Treiber G, Ammon S, Klotz U.
    Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
    [Abstract] [Full Text] [Related]

  • 17. Acid-inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori-negative healthy subjects.
    Geus WP, Mulder PG, Nicolai JJ, Van den Boomgaard DM, Lamers CB.
    Aliment Pharmacol Ther; 1998 Apr; 12(4):329-35. PubMed ID: 9690721
    [Abstract] [Full Text] [Related]

  • 18. Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo.
    Hamilton MI, Sercombe J, Pounder RE.
    Dig Dis Sci; 2002 Jan; 47(1):54-7. PubMed ID: 11837732
    [Abstract] [Full Text] [Related]

  • 19. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W, Ripke H, Kleist P, Ehrlich A, Wieckhorst G, Lücker PW, Fuder H.
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
    Takeda H, Hokari K, Asaka M.
    J Clin Gastroenterol; 1995 Sep; 20 Suppl 1():S7-9. PubMed ID: 7673616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.